AIHL.F Stock Overview
Engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Adcock Ingram Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R2.45 |
| 52 Week High | R2.45 |
| 52 Week Low | R2.45 |
| Beta | 0.28 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| AIHL.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 2.2% |
| 1Y | n/a | 9.9% | 31.6% |
Return vs Industry: Insufficient data to determine how AIHL.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how AIHL.F performed against the US Market.
Price Volatility
| AIHL.F volatility | |
|---|---|
| AIHL.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AIHL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AIHL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1890 | n/a | Andy Hall | www.adcock.co.za |
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products in oral solid dosage formulations, syrups, intravenous, and injectable dosage forms.
Adcock Ingram Holdings Limited Fundamentals Summary
| AIHL.F fundamental statistics | |
|---|---|
| Market cap | US$442.59m |
| Earnings (TTM) | US$47.98m |
| Revenue (TTM) | US$487.67m |
9.2x
P/E Ratio0.9x
P/S RatioIs AIHL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIHL.F income statement (TTM) | |
|---|---|
| Revenue | R9.13b |
| Cost of Revenue | R5.98b |
| Gross Profit | R3.15b |
| Other Expenses | R2.25b |
| Earnings | R898.41m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.88 |
| Gross Margin | 34.53% |
| Net Profit Margin | 9.84% |
| Debt/Equity Ratio | 0.2% |
How did AIHL.F perform over the long term?
See historical performance and comparison